Soleus Capital Management »

Hologic shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Hologic (HOLX) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Hologic

Tip: Access up to 7 years of quarterly data

All positions including Hologic held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hologic by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 34k 71.45
2022-03-31 $17M 226k 76.82

More positions owned by Soleus Capital Management

Teva Pharmaceutical Inds Sponsored Ads (TEVA)
United Therapeutics Corporation (UTHR)
GSK Sponsored Adr (GSK)
Rayzebio
Edap Tms S A Sponsored Adr (EDAP)
Organogenesis Hldgs (ORGO)
Humana (HUM)
Celcuity (CELC)
Iradimed (IRMD)
Essa Pharma Com New (EPIX)
SurModics (SRDX)
Hca Holdings (HCA)
Vaxcyte (PCVX)
Neuropace (NPCE)
Nuvalent Inc-a (NUVL)

View all positions for Soleus Capital Management

Top funds holding Hologic

Vanguard Group
Victory Capital Management
T. Rowe Price Associates
Citadel Advisors
Norges Bank Investment Management
Parnassus Investments
Dimensional Fund Advisors
Legal & General Group
Millennium Management
Bank of America Corporation
TD Asset Management
Bnp Paribas Investment Partners
Wellington Management Company
Amundi
Earnest Partners

View all funds holding Hologic